Everyone has a set of superpowers. An easy way to boost not just your self-confidence but also your happiness & efficacy is to determine what these are & practice them regularly! Look for the things that come naturally to you, but seem to amaze & delight others: in the work...1/4
...setting, could be your way of drilling down on the components of a problem or solution, your ability to zoom out to a strategic view on a situation, your Tweets or blog posts, or how you inspire a team. In the personal setting, could be the cheer you bring in a quick...2/4
...call to a friend who is down or your creativity in your kids' play. Also help others recognize theirs w/ appreciation & explicit acknowledgement of where they shine. Not only will this mean you'll get more of their [mentorship, strategic thinking, awesome banana bread],...3/4
...you'll be helping them learn more about themselves. Sometimes we discount anything that isn't challenging, but it's actually nice to recognize where you can take a quick beat in the day to add value to your team or a loved one by just contributing your own unique energy. 4/4

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Sara Nayeem

Sara Nayeem Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @SaraNayeem

22 Jul
We all know that team is a huge part of an investment thesis. Thus, I’m always surprised when biopharma co’s undersell their ppl in their pitch. A few suggestions: first, include a team slide close to the beginning of the deck & put more info rather than less about each exec. 1/9
...Head shots are a must & ideally you’re including past roles (w/ titles). Just showing logos of past co's at which ppl have worked may make the slide look cooler, but it doesn’t really communicate very much in terms of level of responsibility, where in the organization...2/9
...someone worked, length of the role, etc. Another helpful element to include is any approved drugs (or even those in the clinic currently) that your team members helped develop. (Logos work great for drugs!) Also, if a team member is going to be participating in the pitch...3/9
Read 9 tweets
14 Jul
For biopharma co's pitching VCs, always think about how you can contextualize your data. Positive controls (“benchmarking data”) utilized in the same study as your active agent are the best way to do this in the preclinical setting. (Think carefully about how these...1/8
...comparators are dosed – aiming to achieve the equivalent concentration or exposure as used clinically is reasonable.) But even if that’s not possible (relevant agents can’t be obtained / made), think about what other preclinical or clinical data can provide meaning to...2/8
...your study results. Perhaps a competing molecule in development was studied in the same model and you can reference that data. Or perhaps there’s relevant preclinical AND clinical data on an abandoned compound with the same MoA (e.g., had some clinical efficacy but also...3/8
Read 8 tweets
7 Jul
A key challenge of a good pitch is to present the info in a thoughtful order. W/ regard to corporate elements, most inv's like to hear about the team close to the beginning & cover financing hx / current financing round early on too. These topics provide helpful context...1/4
...before jumping into the science. After that, consider presenting the platform (if relevant), then going program by program. For each program, inv's will want to understand disease state/unmet need, current SOC, competition, science behind your MoA & then program-specific...2/4
...data (incl. IP). Can be useful to provide a sense for how large the markets are you're pursuing, clinical plan, etc. If you're in the clinic but pre-PoC, make sure to include your PC efficacy results. Include use of proceeds at the end too. Sometimes co's want to make a... 3/4
Read 4 tweets
11 Jun
One effective way to move investors along in diligence, particularly once they're under CDA & clearly interested, is to offer up some next steps. "We're happy to put in you in touch with some of our scientific advisors." "We could do a call on our SAR if that would help." 1/5
...When mgt offers up explicit next steps, they save investors time in terms of coming up with their own list and then reaching out to ask. Throwing in something like (if true), "this has been helpful for other groups" or "they've agreed to speak with other investors" clues...2/5
...ppl into what competing VCs think are relevant lines of inquiry, & also signals that others are excited - that's a good thing! Of course, having a more fulsome deck that can be reviewed under CDA is a first step, but these tactics can help shorten the time to doing...3/5
Read 5 tweets
28 May
Most co's will disclose the post on their last round in the initial, non-con presentation. A few don't. Arguments for disclosing it: 1) you save time; if it's really high and you expect a step-up, you can exclude those inv's who don't feel strongly enough about the co to...1/6
..."get there" - and note that if you feel it was priced too high (e.g., strategic-led, mkt has had a dramatic shift) you can subtly indicate that; 2) if your post is particularly attractive, it might actually pull in someone who is on the fence on whether to prioritize...2/6
...your co near the top - this *doesn't mean* that anyone expects you to price at the last post! You can certainly explicate on all the progress since the last round if you'd like, but rest assured that no one thinks last post = current pre. I'd also note that some inv's...3/6
Read 6 tweets
27 May
If you suffer from imposter syndrome, a good way to actively combat it is to simply help someone professionally. Better yet, work time into your schedule to do this each week. In my field (biopharma VC), this might mean calling a portfolio company CEO to check in / offer...1/5
...help on some initiative; mentoring or sharing deal flow with a talented younger investing professional; taking extra time to give feedback to a company I liked but where I passed (for now), if that’s useful to them; or even just serving on a panel or penning a Tweet. 2/5
...There are multiple ways in which this approach assuages imposter syndrome: 1) you are immediately reminded of your expertise and contributions, and probably of why you chose the field you’re in to start with; 2) experiencing someone’s gratitude tends to make us more...3/5
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!